Clinical Trial Update: Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy with cabazitaxel in bone-metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis
• Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Bone Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED